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Dr Newburgers
doi:10.1016/j.jtcvs.2007.03.067bjective: Two randomized trials of hematocrit strategy during hypothermic 
iopulmonary bypass in infant heart surgery have been performed. The firs
ested worse outcomes were concentrated in patients with lower hematocrit 
approximately 20%), whereas the second suggested there was little bene
ncreasing the hematocrit level above 25%. The form of the relationship be
ontinuous hematocrit levels and outcomes requires further study.
ethods: In the two trials, 271 infants who underwent biventricular repai
nvolving the aortic arch were enrolled. Analysis was undertaken of the effe
ematocrit level, as a continuous variable, at the onset of low-flow cardiopulmonary b
esults: Psychomotor Development Index scores at age 1 year varied nonlin
ith hematocrit levels, with increasing scores up to 23.5% hematocrit (P  .001)
nd a plateau effect beyond 23.5% (P  .42), based on a piecewise linear mod
ower hematocrit levels were associated with more positive intraoperative 
alance (P  .001 for linear trend) and marginally associated with higher s
actate levels at 60 minutes after bypass (P  .08 for linear trend), but not w
lood products given, nadir of cardiac index in the first 24 hours, or 
evelopment Index scores.
onclusions: A hematocrit level at the onset of low-flow cardiopulmonary bypa
pproximately 24% or higher is associated with higher Psychomotor Develop
ndex scores and reduced lactate levels. Because the effects of hemodilution
ary according to diagnosis, age at operation, bypass variables such as pH s
nd flow rate, and other perioperative factors, this study cannot ascertain a 
ally “safe” hemodilution level.
emodilution during hypothermic cardiopulmonary bypass (CPB) was u
initially in the 1950s, with the rationale that it would reduce the 
blood and blood products,1 as well as improve perfusion in microvesse2
ubsequently, concerns emerged about potential adverse effects of hemodilu
ncluding reduced perfusion pressure, increased cerebral blood flow and h
ncreased risk for cerebral microemboli, and decreased oxygen-carrying capacit3-5
We6 previously conducted a randomized trial of 147 patients, of whom 74
ssigned to a lower-hematocrit strategy at onset of low-flow CPB (21.5%  2.9%,
ean  SD, with a target of 20%) and 73 to a higher-hematocrit strategy (27
.2%, with a target of 30%). The lower-hematocrit group had higher intraope
uid balance, higher serum lactate levels 60 minutes after cessation of CPB,
adirs of cardiac index in the first 24 hours, and, at age 1 year, worse Psyc
evelopment Index (PDI) scores, although Mental Development Index (Mcores were similar between groups. Because we could not determine a specific
The Journal of Thoracic and Cardiovascular Surgery ● Volume 135, Number 2 355
t
s
3
o-
t
a
(
h
T
6
i
t
b
t
c
p
c
t
t
1
P
T
v tion
l
2
m e
i
c
s
a
c
r
g
q
c
p
i
i
i n.
F
a
c
C
d
w
l
m
i
t
w
m
P
m
o
S
O
m
a
s
n
M
y  to
fl
b
o
l
l
e on
p
m
i
t
l
o
o
o
i
h
m
t
m the
e
i
i
1
e
t
t
s ed
a
c
Surgery for Congenital Heart Disease Wypij et al
3
CH
Darget hematocrit level that was optimal, we embarked on a
econd randomized trial of target hematocrit 25% versus
5% in a similar study population.
A companion article7 presents results from an intent-t
reat analysis of 124 patients, of whom 56 were assigned to
medium-hematocrit strategy at onset of low-flow CPB
24.8%  3.1%, with a target of 25%) and 68 to a higher-
ematocrit strategy (32.6%  3.5%, with a target of 35%).
hese two treatment groups had similar serum lactate levels
0 minutes after cessation of CPB, nadirs of cardiac index
n the first 24 hours, PDI scores, and MDI scores, although
he 25% hematocrit group had higher intraoperative fluid
alance and, only in a subgroup with dextro-transposition of
he great arteries (D-TGA), longer hospital stay. We con-
luded that hemodilution to hematocrit levels of 35% com-
ared with 25% had marginal clinical benefits and no in-
reased risks.
In this article, we combine the data from these two trials
o attempt to identify, in more quantitative terms, the rela-
ionship of hemodilution level to key postoperative and
-year developmental outcomes.
atients and Methods
he protocols for both hematocrit trials have been described pre-
iously6,7 and were similar except for the targeted hemodilu
evels. We enrolled patients between November 1996 and July
004 at Children’s Hospital Boston. Eligibility criteria are sum-
arized elsewhere and were identical in both trials.6,7 In brief, w
ncluded infants under age 9 months with congenital heart lesions
omprised of two ventricles without aortic arch obstruction, ab-
ence of suspected or definite genetic disorders or congenital
nomalies of more than minor severity, and no previous or planned
ardiac surgery before the 1-year developmental evaluation. Pa-
ental informed consent was obtained according to institutional
uidelines.
Of 424 eligible infants for whom informed consent was re-
uested, 278 patients were enrolled; of these, 7 (3%) were ex-
luded post hoc because the operation was not performed as
lanned or because the patient was discovered to have been inel-
gible after further clinical information was obtained. The remain-
ng 271 patients underwent reparative surgical intervention accord-
ng to the study protocols6,7 and constitute the study populatio
ull-flow CPB (2.5 L · min1 · m2) was used during cooling
Abbreviations and Acronyms
CI  confidence interval
CPB  cardiopulmonary bypass
D-TGA dextro-transposition of the great arteries
MDI Mental Development Index
PDI  Psychomotor Development Index
TOF  tetralogy of Fallot
VSD  ventricular septal defectnd rewarming. Some patients had periods of deep hypothermic o
56 The Journal of Thoracic and Cardiovascular Surgery ● Febrirculatory arrest, and most had at least one period of reduced-flow
PB, for example, at approximately 0.75 L · min1 · m2 when at
eep hypothermia (rectal temperature  18°C). For patients in
hom low-flow CPB was not used, we analyzed the hematocrit
evel 10 minutes after onset of cooling.
Participating infants were randomly assigned to undergo he-
odilution to a hematocrit level of approximately 20% versus 30%
n the first trial and approximately 25% versus 35% in the second
rial. Treatment assignments were based on randomized blocks
ith stratification according to surgeon and diagnostic group. The
ethod of support was assigned immediately before the operation.
erfusionists and study nurses were aware of treatment assign-
ent. Surgeons, anesthesiologists, cardiac intensivists, and devel-
pmental psychologists were blinded to treatment assignment.
tatistical Analyses
utcomes included the perioperative and 1-year develop-
ent variables that were the primary outcome variables for
t least one of the two hematocrit trials. These include
erum lactate levels 60 minutes after cessation of CPB,
adir of cardiac index in the first 24 hours, and the PDI and
DI of the Bayley Scales of Infant Development at age 1
ear.8 We also explored the relationship of hematocrit
uid balance, use of blood products, and duration of intu-
ation, intensive care unit stay, and hospital stay.
Analyses assessing the effects of hematocrit at the onset
f low-flow CPB as a continuous variable on outcomes used
inear regression, proportional hazards regression for
ength-of-stay variables, and generalized additive mod-
ls.9,10 Generalized additive models are methods of n-
arametric regression smoothing that allow for the assess-
ent of any effect of hemodilution level on outcome,
ncluding nonlinear effects, as well as assessment of depar-
ure of linearity or piecewise linearity of effect. Piecewise
inear (or cut point) regression models were used to model
utcomes that had significant nonlinear trends with hemat-
crit level. Confidence intervals for cut points were based
n inversion of likelihood ratio tests.11 All likelihood max-
mizations and likelihood ratio tests searched over a grid of
ematocrit levels in 0.5% increments. Quadratic regression
odels were also considered but did not fit the data better
han either generalized additive models or piecewise linear
odels. We12 have used similar methods to assess 
ffects of duration of deep hypothermic circulatory arrest in
nfant heart surgery on late neurodevelopment.
All regression analyses adjust for diagnostic group and,
f statistically significant, year of operation (coded as 1996–
998, 1999 –2000, 2001–2002, and 2003–2004). We also
xplored whether intraoperative support variables (dura-
ions of crossclamp, total support, total CPB, and circula-
ory arrest) and, in the case of the Bayley Scales, family
ocial class13 independently predicted outcomes or serv
s confounders of the effect of hematocrit level on out-
omes. Other tests for association used analysis of variance
r Spearman rank correlation coefficients. All P values are
uary 2008
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D-tailed and we selected a level of significance of .05 for
ypothesis testing.
esults
escriptive statistics on preoperative and operative charac-
eristics of the 271 combined study patients are included in
able 1. Hematocrit levels at the onset of low-flow 
anged from 16% to 39% and were not associated with
ABLE 1. Preoperative and operative characteristics of 271
atients undergoing hypothermic CPB in infant heart
urgery
ariable Mean  SD
reoperative characteristics
Birth weight (kg) 3.4  0.6
Gestational age (wk) 39.1  1.5
Apgar score at 5 min 8.6  0.9
Age at operation (d), median (range) 41 (1–269)
Sex (% male) 65
Race (% nonwhite) 20
Diagnosis, n (%)
D-TGA group
D-TGA, IVS 61 (23)
D-TGA, VSD 47 (17)
TOF group
TOF 71 (26)
TOF, PA 7 (3)
Truncus arteriosus 13 (5)
VSD group
VSD 65 (24)
Complete common AV canal 7 (3)
Ever intubated (%) 38
Overall neurologic examination result
(% abnormal)
62
perative characteristics
Hematocrit level at onset of low-flow CPB (%) 26.5  5.3
16%–20%, n (%) 37 (14)
21%–25% 84 (31)
26%–30% 85 (31)
31%–35% 49 (18)
36%–39% 16 (6)
Crossclamp time (min) 65  26
Total support time (min) 108  37
Total CPB time (min) 100  32
Duration of circulatory arrest (min) 8  13
None, n (%) 153 (56)
1–10 53 (20)
11–30 43 (16)
31–44 16 (6)
45 6 (2)
PB, Cardiopulmonary bypass; SD, standard deviation; D-TGA, dextro-
ransposition of the great arteries; IVS, interventricular septum; VSD,
entricular septal defect; TOF, tetralogy of Fallot; PA, pulmonary atresia;
V, atrioventricular.iagnostic group (26.6%  5.2%, mean  SD, for the s
The Journal of Thoracic-TGA group; 26.2%  5.5% for the tetralogy of Fallot
TOF] group; and 26.9%  5.2% for the ventricular septal
efect [VSD] group; analysis of variance P  .64) or with
uration of crossclamp (Spearman rank correlation r 
.04, P  .53), total support (r  0.03, P  .61), total CPB
r  0.03, P  .68), or circulatory arrest (r  0.004, P 
95). One infant (0.4%) died within 1 month of the
peration.
erioperative Outcomes
escriptive statistics on perioperative and 1-year outcomes
re included in Table 2. We assessed the relationshi
ematocrit level at the onset of low-flow CPB to intraoper-
tive fluid balance. In generalized additive models adjusting
or diagnostic group and year of operation, we found no
ignificant departures from linearity (P  .83). In linear
egression models adjusting for diagnostic group and year
f operation, increasing hematocrit level was significantly
ssociated with decreasing fluid balance; each 1-point in-
rease in hematocrit level was associated with an 11.8-mL
ecrease in intraoperative fluid balance (95% confidence
nterval [CI]  5.5-18.1 mL; P  .001, Figure 1, A).
ndependent predictors of higher intraoperative fluid bal-
nce included diagnostic group (D-TGA highest, TOF inter-
ediate, VSD lowest; P  .001), later year of operation
P  .001), and longer crossclamp, total support, and total
PB times (P  .001 for each), but not duration of circu-
atory arrest. Inclusion of these support times in the multi-
ariable linear model further increased the strength of the
elationship of higher hematocrit at onset of low-flow CPB
o lower intraoperative fluid balance.
Although higher fluid balance was significantly associ-
ted with longer time until endotracheal intubation, inten-
ABLE 2. Perioperative and 1-year outcomes of 271 pa-
ients undergoing hypothermic CPB in infant heart surgery
ariable n Mean  SD
erioperative outcomes
Intraoperative fluid balance (mL) 244 401 259
Intraoperative blood products (mL),
median (range) 270 208 (25–1383)
Serum lactate at 60 min after CPB
(mmol/L) 239 2.9 1.6
Nadir of cardiac index (L · min1 ·
m2) 102 3.1 1.1
Postoperative blood products (mL),
median (range) 271 111 (0–3551)
ne-year outcomes
PDI 215 86.2  15.7
MDI 216 93.9  12.4
PB, Cardiopulmonary bypass; SD, standard deviation; PDI, Psychomotor
evelopment Index; MDI, Mental Development Index.ive care unit discharge, and hospital discharge, hematocrit
and Cardiovascular Surgery ● Volume 135, Number 2 357
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Devel at the onset of low-flow CPB was not an independent
redictor of these measures of prolonged recovery in mul-
ivariable models adjusting for diagnosis or year of opera-
ion. Furthermore, analyses within diagnostic groups also
id not show associations between hematocrit level and
ength-of-stay variables.
We assessed the relationship of hematocrit level at the
nset of low-flow CPB to serum lactate levels at 60 minutes
fter cessation of CPB. In generalized additive models ad-
usting for diagnostic group, we found no significant depar-
ures from linearity (P  .73). In linear regression models
djusting for diagnostic group, higher hematocrit level was
arginally associated with lower lactate level; each 1-point
ncrease in hematocrit level was associated with a 0.027
mol/L decrease in serum lactate levels at 60 minutes after
essation of CPB (95% CI  0.003-0.057 mmol/L; P 
08, Figure 1, B). Independent predictors of higher seru
actate included diagnostic group (D-TGA highest, TOF
ntermediate, VSD lowest; P  .001), longer total support
ime (P  .009), and longer duration of circulatory arrest
P  .001). Inclusion of these support times in the multi-
ariable linear model increased the strength of the relation-
hip of higher hematocrit level at onset of low-flow CPB to
uid balance also adjust for year of operation. Generalized additi
alues of these adjustment factors.ower serum lactate levels. m
58 The Journal of Thoracic and Cardiovascular Surgery ● FebrNadir of cardiac index was measured in only 102 pa-
ients. Adjusting for diagnostic group, we found no signif-
cant departures from linearity of the effects of hematocrit
evel on nadir of cardiac index (P  .44) and no significant
inear effects of hematocrit level on nadir of cardiac index
P  .24). The only independent predictor of nadir of
ardiac index was diagnostic group (D-TGA lowest, TOF
ntermediate, and VSD highest; P  .001).
We measured the use of blood products intraoperatively
nd in the postoperative period. Adjusting for diagnostic
roup and, for intraoperative blood products only, year of
peration, there were no significant departures from linear-
ty and no significant linear effects in the relationships of
ematocrit level to intraoperative or postoperative blood
roduct use. Independent predictors of higher intraoperative
lood products included diagnostic group (D-TGA highest,
OF intermediate, VSD lowest; P  .001), later calendar
ear of operation (P  .004), and longer crossclamp, total
upport, and total CPB times (P  .001 for each), but not
uration of circulatory arrest. Independent predictors of
igher postoperative blood products included longer cross-
lamp, total support, total CPB, and circulatory arrest times
P  .001 for each). Inclusion of these support times in the
Figure 1. Scatterplots of outcomes as
a function of hematocrit level at the
onset of low-flow CPB. The panels rep-
resent intraoperative fluid balance (A),
serum lactate levels at 60 minutes after
cessation of CPB (B), Psychomotor De-
velopment Index (C), and Mental De-
velopment Index (D). The solid lines
were derived through generalized ad-
ditive models, with pointwise 95%
confidence limits for hematocrit ef-
fects denoted as dashed lines. The dot-
dash lines denote the fitted linear
regression models. In the case of Psy-
chomotor Development Index, the dot-
dash line denotes the fitted piecewise
linear regression model, based on the
optimal cut point of 23.5% hematocrit.
The P values assess the strength of the
relationship between hematocrit on
outcome in adjusted linear regression
models. For Psychomotor Development
Index, the top P value corresponds to
the effect before and the bottom P
value corresponds to the effect after
the optimal cut point of 23.5% hemato-
crit. All models adjust for diagnostic
group and models for intraoperative
odel fits and linear regression model fits are plotted for averageve multivariable linear models did not affect the lack of sig-
uary 2008
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Dificant association between hematocrit levels and postop-
rative blood products.
ne-year Outcomes
e assessed the relationship of hematocrit at the onset of
ow-flow CPB to PDI scores at age 1 year. In generalized
dditive models adjusting for diagnostic group, we found
ignificant departures from linearity (P  .008). Evaluation
f piecewise linear models over a grid of hematocrit cut
oints led to an optimal cut point of 23.5%, with a 95% CI
rom 21.0% to 29.5%. In a piecewise linear model, each
-point increase in hematocrit up to 23.5% was associated
ith a 2.6-point increase (slope) in PDI scores (95% CI 
.1-4.2; P  .001). However, increasing hematocrit level
bove 23.5% was not significantly associated with PDI
cores (slope  0.2, 95% CI 0.8-0.3; P  .42), and PDI
cores had effectively reached a plateau by a hematocrit
evel of 23.5% (Figure 1, C). The two slopes (ie, below 
bove hematocrit levels of 23.5%) were significantly different
P .003). Generalized additive models showed no significant
vidence of departure from the piecewise linear model (P 
32). Choice of other cut points led to similar inferences.
ntraoperative support times and social class did not serve as
ignificant independent predictors of PDI scores.
We assessed the relationship of hematocrit at the onset of
ow-flow CPB to MDI scores at age 1 year. Adjusting for
iagnostic group, we found no significant departures from
inearity of the effects of hematocrit on MDI scores (P  .34)
nd no significant linear effects of hematocrit on MDI (P 
26) (Figure 1, D). Higher family social class was indep
ently associated with higher MDI scores (P  .001).
iscussion
e found that PDI scores at age 1 year varied nonlinearly
ith hematocrit levels, with significantly increasing scores
p to 23.5% hematocrit and a plateau effect beyond 23.5%
ematocrit, based on a piecewise linear model. Lower he-
atocrit levels were significantly associated with higher
uid balance and marginally associated with higher serum
actate levels at 60 minutes after CPB, but not associated
ith nadir of cardiac index in the first 24 hours, blood
roducts given, or MDI scores. It may be appropriate to
arget hematocrit level at the onset of low-flow CPB to be at
east 24%, inasmuch as lower hematocrit levels are associ-
ted with worse PDI scores and a tendency for higher lactate
evels, whereas higher hematocrit levels were not associated
ith adverse events or outcomes.
The correlation/linear regression methods used in previ-
us studies, which force a linear fit to the relationship
etween hemodilution and outcomes, are problematic if
here is a nonlinear trend between these variables. In par-
icular, the overall slope or correlation is a weighted average
f the slopes or correlations over the whole range of t
The Journal of Thoracicematocrit values, which could underestimate the effects
f hemodilution over certain ranges of hematocrit values
f there are nonlinear trends. Our use of nonparametric
egression smoothing and piecewise linear regression
rovided an opportunity to identify potential cut points in
hese associations.
We found no relationship of hematocrit level at the onset
f low-flow CPB with usage of blood products in the
perating room or during the postoperative period. Animal
odels of hematocrit strategy have shown that hemodilu-
ion not only reduces oxygen-carrying capacity, but also
educes osmolality, viscosity, and perfusion pressure, as
ell as diluting platelets and coagulation factors.4,14 The
ack of association of hematocrit levels with blood product
se may reflect improved hemostasis with higher hematocrit
evels.
Laboratory studies have demonstrated the important
nteraction of hematocrit with temperature, pH strategy, and
uration of circulatory arrest or very reduced flow.15,16
pecifically, animal models have demonstrated that it is
ossible to compensate for the reduced oxygen-carrying
apacity of low hematocrit by increasing oxygen availabil-
ty by the pH-stat strategy or by increasing flow rate, re-
ucing duration of circulatory arrest, or reducing tempera-
ure. In both hematocrit trials, we used the pH-stat strategy,
eep hypothermia in many patients, and minimal periods of
xtended circulatory arrest or very low-flow CPB. These
spects of the intraoperative milieu, together with the po-
ential inclusion of some infants with undetected genetic
yndromes, may have limited our power to detect effects of
ematocrit on some outcomes.
Our analyses should be interpreted in light of several
dditional limitations. Both hematocrit trials were con-
ucted in a single center and included only infants under-
oing reparative cardiac surgery for congenital heart defects
nvolving two ventricles without aortic arch obstruction.
hese aspects of the study could limit generalizability to
ther centers and congenital heart lesions. Furthermore,
lthough we excluded infants with known or suspected
enetic or congenital anomalies, the study protocols did not
equire fluorescent in situ hybridization studies to exclude
enetic disorders; the inadvertent inclusion of some children
ith genetic disorders could have diminished the effect of
ematocrit level on 1-year neurodevelopmental outcomes.
In summary, we found that the effect of hemodilution
evel on PDI scores is nonlinear, with improving scores with
ncreases in hematocrit level at the onset of low-flow CPB
p to approximately 24%, followed by a plateau. Increasing
ematocrit levels were also marginally related to a reduction
n serum lactate levels 60 minutes after cessation of CPB.
his study cannot ascertain a universally optimal hematocrit
evel because of potential influences of patient characteris-
ics and other intraoperative factors, but at Children’s Hos-
and Cardiovascular Surgery ● Volume 135, Number 2 359
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Dital Boston, we try to ensure that hematocrit level will be
bove 25% at commencement of CPB and during CPB and
ewarming. Future multicenter investigations should ascer-
ain late neurodevelopmental status after infant cardiac sur-
ery and study other populations, including adults, to help
o clarify optimal hematocrit levels during CPB.
We thank our perfusionists: Willis G. Gieser, CCP, Robert A.
aPierre, BS, CCP, Robert J. Howe, BS, CCP, Gregory S. Matte,
CP, and William L. Regan; our nursing staff in the Cardiac
ntensive Care Unit for assistance with adherence to the protocols;
udmila Kyn for database and statistical programming; Donna
onati, Donna Duva, and Lisa-Jean Buckley for data management;
athleen Alexander for project coordination; and families and
hildren in the cohort for their time and effort.
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